Overexpression of ZEB-AS1 promoted tumor development in prostate cancer by epigenetically upregulating zinc finger homeodomain enhancer-binding protein (ZEB1) expression, further activating the downstream target gene of ZEB1 [33]. The gene discussed is ZEB1; the disease is prostate carcinoma.